The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

Dianne Bosch; Kim J.M. van der Velden; Irma M. Oving; Dirk N.J. Wyndaele; Leo E. Weijs; W. Dick van Schelven; Wim J.G. Oyen; Erik T. te Beek; Addy C.M. van de Luijtgaarden; Diederik M. Somford; James Nagarajah; Rick Hermsen; Niven Mehra; Winald R. Gerritsen; Maarten J. van der Doelen; Inge M. van Oort

doi:10.2967/jnumed.123.266654

Research ArticleClinical Investigation

The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of ²²³Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

Dianne Bosch, Kim J.M. van der Velden, Irma M. Oving, Dirk N.J. Wyndaele, Leo E. Weijs, W. Dick van Schelven, Wim J.G. Oyen, Erik T. te Beek, Addy C.M. van de Luijtgaarden, Diederik M. Somford, James Nagarajah, Rick Hermsen, Niven Mehra, Winald R. Gerritsen, Maarten J. van der Doelen and Inge M. van Oort

Journal of Nuclear Medicine February 2024, jnumed.123.266654; DOI: https://doi.org/10.2967/jnumed.123.266654

Dianne Bosch

1Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kim J.M. van der Velden

1Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Irma M. Oving

2Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dirk N.J. Wyndaele

3Department of Nuclear Medicine, Catharina Hospital, Eindhoven, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Leo E. Weijs

4Department of Radiology and Nuclear Medicine, Ziekenhuisgroep Twente, Almelo, Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

W. Dick van Schelven

5Department of Nuclear Medicine, Medical Center Leeuwarden, Leeuwarden, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wim J.G. Oyen

6Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands;

7Department of Biomedical Sciences, Humanitas University, Milan, Italy;

8Department of Nuclear Medicine, Humanitas Clinical and Research Center, Milan, Italy;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Erik T. te Beek

9Department of Nuclear Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Addy C.M. van de Luijtgaarden

10Department of Medical Oncology, Reinier de G raaf Gasthuis and Reinier Haga Prostate Cancer Center, Delft, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Diederik M. Somford

11Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James Nagarajah

12Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rick Hermsen

13Department of Nuclear Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Niven Mehra

14Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Winald R. Gerritsen

14Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maarten J. van der Doelen

1Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Inge M. van Oort

1Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of 223Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of ²²³Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

Journal of Nuclear Medicine Feb 2024, jnumed.123.266654; DOI: 10.2967/jnumed.123.266654

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of ²²³Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

Journal of Nuclear Medicine Feb 2024, jnumed.123.266654; DOI: 10.2967/jnumed.123.266654

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

223Ra
computer tomography
castration-resistant prostate cancer
overall survival
PSMA PET/CT

Main menu

User menu

Search

The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of ²²³Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords